Severe bullous pemphigoid in an infant - Successful treatment with rituximab

Pediatric Dermatology

Volumn 25, Issue 4, 2008, Pages 462-465

  Schulze, Johannes ^a   Bader, Peter ^a   Henke, Ulrike ^a   Rose, Markus A ^a   Zielen, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CD19 ANTIBODY; CLEMASTINE FUMARATE; CYCLOSPORIN A; DAPSONE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PIMECROLIMUS; PREDNISONE; RITUXIMAB;

ARTICLE; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; CASE REPORT; CUSHINGOID SYNDROME; DRUG DOSE REDUCTION; DRUG FEVER; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MALE; PATIENT REFERRAL; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PRURITUS; RASH; SINGLE DRUG DOSE; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PEMPHIGOID, BULLOUS;

EID: 49349089794     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00751.x     Document Type: Article

References (12)

1. Fisler RE, Saeb M, Liang MG et al. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol 2003 25 : 183 189.
2. Schmidt E, Hunzelmann N, Zillikens D et al. Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol 2006 31 : 503 508.
3. Petronius D, Bergman R. Bullous pemphigoid in two young infants. Pediatr Dermatol 2002 19 : 119 121.
4. Thivolet J, Barthelemey H, Rigot-Muller G et al. Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet 1985 1 : 334 335.
5. Farrell AM, Kirtschig G, Dalziel KL et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol 1999 140 : 308 312.
6. Tripoldi G, Risso M, Tenerini L et al. Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporal photochemotherapy. J Clin Apher 2007 22 : 26 30.
7. Giulino L, Bussel J, Neufeld E. Treatment with rituximab in benign and malignant hematologic disorders in children. J Pediatr 2007 150 : 338 344.
8. Ahmed AR, Spigelman Z, Cavacini LA et al. Treatment of pemphigus vulgaris with rituximab and intravenous immunoglobulin. N Engl J Med 2006 355 : 1772 1779.
9. Joly P, Mouquet H, Roujeau JC et al. A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 2007 257 : 545 552.
10. Kong HH, Prose NS, Ware RE et al. Successful treatment of refractory childhood pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol 2005 22 : 461 464.
11. Connelly EA, Aber C, Kleiner G et al. Generalized erythrodermic pemphigus foeliacus in a child and its successful response to rituximab treatment. Pediatr Dermatol 2007 24 : 172 176.
12. Quartier P, Brethon B, Philippet P et al. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001 358 : 1511 1513.